Joseph Truitt, EVP, Chief Commercial Officer at ACHILLION PHARMACEUTICALS INC (ACHN), sold 50,000 shares at $6.05 ($301K) on 2014-06-10, disclosed to the SEC on 2014-06-11.
Scheduled sale ($301k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.82 | 1,050 | $5K | 1.7% |
| 2 | $6.05 | 48,950 | $296K | 98.3% |
| Total | $6.02 avg | 50,000 | $301K | 100% |
| Filing → |
| ACHN | BUY | 2016-12-05 | $14K | — | Filing → |
| ACHN | SELL | 2014-08-26 | $271K | — | Filing → |
| ACHN | SELL | 2014-06-17 | $196K | — | Filing → |